Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU
This study has been terminated.
( Inadequate enrollment )
Study NCT00048750   Information provided by Astellas Pharma Inc
First Received: November 6, 2002   Last Updated: September 29, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Invasive Fungal Infections
Additional conditions recognized in this trial
Communicable Diseases
Infection
Mycoses
Interventions listed in this trial
Micafungin
Placebo
Additional drug interventions recognized in this trial
Antifungal Agents
More general drug interventions related to this trial
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Astellas Pharma Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services